Vaxart
VXRT
VXRT was delisted on the 7th of July, 2025.
33 hedge funds and large institutions have $9.59M invested in Vaxart in 2013 Q2 according to their latest regulatory filings, with 33 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $344K
Top Buyers
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
Manulife (Manufacturers Life Insurance)
Canada,
Ontario, Canada
| $3K | +$2.78K | +67 | New |
|
|
TRCT
27
Tower Research Capital (TRC)
New York
| $3K | +$3.24K | +78 | New |
|
28
Citigroup
New York
| $3K | +$3.28K | +79 | New |
|
|
LTFS
29
Ladenburg Thalmann Financial Services
Miami,
Florida
| $1K | +$623 | +15 | New |
|
|
AIG
30
American International Group
New York
| $345 | +$374 | +9 | New |
|
31
Bank of America
Charlotte,
North Carolina
| – | +$125 | +3 | New |
|
|
SFS
32
Signator Financial Services
Boston,
Massachusetts
| – | +$125 | +3 | New |
|
33
Barclays
London,
United Kingdom
| – | +$374 | +9 | New |
|
VXRT Hedge Fund Activity: Q2 2013 in Review
33 of the 3,064 institutional investors tracked by Wall St. Rank reported a position in Vaxart (VXRT) for Q2 2013, worth a combined $9.59M.
Buyers outnumbered sellers: 33 funds opened new VXRT positions and 0 closed out — a net gain of 33 holders — while 0 added to existing stakes and 0 trimmed.
- 33 institutional investors held Vaxart (VXRT) as of Q2 2013, up from 0 in Q1 2013.
- Funds reported $9.59M of Vaxart stock for Q2 2013.
- 33 funds opened new Vaxart positions in Q2 2013 and 0 closed out, a net change of +33 holders.
Based on aggregated 13F filings for Q2 2013.